Paterson Symposium 1993- Gene Therapy
1994
Gene Therapy Strategies Discussed at Paterson Symposium 1993
publication
Author Information
Author(s): L.J. Fairbairn, M.A. Cross, J.R. Arrand
Conclusion
Gene therapy shows promise for treating various genetic disorders and cancers, but challenges remain in delivery methods and ensuring long-term efficacy.
Supporting Evidence
- Virus-based delivery systems are currently the most common for gene therapy.
- Adenovirus is being investigated as a vector due to its good safety record.
- Non-viral methods like liposomes and receptor-mediated delivery systems are also being explored.
- Gene therapy has shown potential in treating cystic fibrosis and muscular dystrophy in trials.
- Challenges include ensuring persistent gene expression and targeting the right cells.
Takeaway
Scientists are exploring different ways to deliver genes to treat diseases, like using viruses or other methods, but there are still many challenges to overcome.
Methodology
The symposium reviewed various gene delivery systems, including viral and non-viral methods, and discussed their applications in treating genetic disorders and cancers.
Limitations
Current gene delivery systems have limitations such as poor infectivity and potential safety concerns.
Want to read the original?
Access the complete publication on the publisher's website